Atlas Trials

A Pilot Study of Tralokinumab in Subjects With Moderate to Severe Alopecia Areata

Clinical trial NCT02684097 · COMPLETED

Trial details

NCT number
NCT02684097
Sponsor
Emma Guttman
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Alopecia Areata
Start date
2016-01-01
Primary completion
2017-11-28
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.